Pharmafile Logo
Pharmafocus logo
Advanced Search
Biogen image

Big pharma partners with government over $100m dementia fund

March 17, 2015
Research and Development, Sales and Marketing Alzheimer's, Biogen IDEC, GSK, J&J, JJ, Pfizer, government, jp morgan, lilly

Lilly, Pfizer, GSK, J&J and Biogen Idec are set to join a $100m Dementia Discovery Fund to boost research into …

News
richard_scheller

23andMe assigns chief scientific officer to new unit

March 17, 2015
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing 23andm3, Richard Scheller

US personal genetics firm 23andMe has created a new therapeutics group and appointed pharma veteran Richard Scheller as chief science …

Appointment
23andme image

23andMe to move into drug development

March 16, 2015
Medical Communications, Research and Development, Sales and Marketing 23andME, DNA, Genentech, Pfizer, google

The Google-backed DNA test company 23andMe has announced plans to start using genetic data to design new drugs. In recent …

News
NHS image

NHS is struggling to improve cancer care

March 16, 2015
Sales and Marketing CRUK, Cancer, Department of Health, NHS, NHS England, oncology

The Department of Health and NHS England are struggling with the demand required to improve its cancer services according to …

News
Sanofi image

Sanofi and Amgen cholesterol drugs shine

March 16, 2015
Sales and Marketing Amgen, PCSK9, Repatha, Sanofi, alirocumab, evolocumab, praluent

Two large Phase III studies of Sanofi’s Praluent and Amgen’s Repatha have found the biologic cholesterol-lowering drugs are more effective …

News
Ofev image

Boehringer eyes Ofev success in IPF and beyond

March 16, 2015
Sales and Marketing Boehringer, Esbriet, Roche, ingelheim, inpulsis, ipd, ofev

Experts say the launch of Boehringer Ingelheim’s new treatment for idiopathic pulmonary fibrosis (IPF) offers stiff competition to Roche’s Esbriet …

News
Science image

Drug development contracts: can lessons be learned from healthcare delivery?

March 16, 2015
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing CCG, CRO, Les Rose, NHS, drug development, trials

There is a very good question to ask at the beginning of every project: “What does success look like?” If …

Feature
thomas_beck

Recipharm appoints quality management VP

March 16, 2015
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Recipharm, thomas beck

Contract development and manufacturing organisation Recipharm has appointed Thomas Beck to the new senior role of vice president of quality …

Appointment
ABPI image

Pharma pays £310 million underwriting UK meds bill

March 13, 2015
Sales and Marketing ABPI, NHS, PPRS, body, department, health pricing, pharma

Pharma has made a fourth quarter payment of £81 million to underwrite the 2014 UK medicines bill under the Pharmaceutical …

News
BMS image

BMS resubmits hepatitis C drug

March 13, 2015
Sales and Marketing BMS, NDA, daclatasvir gilead, hepatitis C, sovaldi

Bristol-Myers Squibb has resubmitted its hepatitis C (HCV) treatment for FDA approval despite previously backing out, as it spots a …

News
Lyrica image

Blow for Pfizer as Lyrica misses target

March 13, 2015
Sales and Marketing FDA, Lyrica, Pfizer, fibromyalgia, pain, pregablin

A late-stage study of Pfizer’s Lyrica has failed to demonstrate it has any significant pain reduction in patients with fibromyalgia. …

News
GSK image

GSK sells off stake in Aspen for $853m

March 13, 2015
Sales and Marketing Africa, China, GSK, Novartis, Singapore, aspen, merger, redfern

GlaxoSmithKline has sold off half its stake in South Africa’s Aspen Pharmacare in a move that will net the British …

News
Takeda HQ, Tokyo image

Takeda gets NICE nod for bowel treatment

March 13, 2015
Sales and Marketing NHS, NICE, Takeda, enyyvio, vedolizumab

Takeda’s Entyvio becomes the first NICE approved gut-selective treatment for UK patients with ulcerative colitis (UC) – a long-term condition …

News
samantha_treadwell

AXON Communications adds five to London team

March 13, 2015
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Axon, bilotta, burns, peregrin, treadwell, ura

UK healthcare comms and PR firm AXON Communications has added five new members to its team in London. Lucie Burns …

Appointment
J&J image

J&J pleads guilty over children’s contaminated medicine

March 12, 2015
Manufacturing and Production, Sales and Marketing FDA, J&J, JJ, McNeil, OTC, Tylenol, consta, hamburg, recall

Johnson & Johnson’s consumer division McNeil has pleaded guilty and will pay fines of $25 million for wrongdoings regarding its …

News

NHS backtracks on Cancer Drugs Fund de-listings

March 12, 2015
Sales and Marketing Afinitor, CDF, Cancer Drugs Fund, England, Halaven, NHS, Novartis, everolimus

NHS England is expected to perform a U-turn on several decisions to remove treatments from the cancer drugs fund when …

News
Salix image

Endo attempts to outbid Valeant for Salix Pharma

March 12, 2015
Sales and Marketing Endo, Valeant, merger, outbid, pharma, salix

Endo has joined the race for Salix, the firm that Valeant reached a $14.5 billion agreement to purchase last month. …

News
GSK image

GSK picks Singapore for Asian hub

March 12, 2015
Manufacturing and Production, Research and Development, Sales and Marketing Asia, GSK, Singapore, Takeda, Witty, emerging markets

Despite GlaxoSmithKline’s ongoing troubles in Asia it has decided to establish a new HQ in Singapore to bolster its presence …

News

UCB sponsors ‘Hack Epilepsy’ digital event

March 12, 2015
Medical Communications, Sales and Marketing Keppra, UCB, epilepsy, hack, lacosamide, levetiracetam, vimpat

Belgian biopharma firm UCB says it will be sponsoring a ‘Hack Epilepsy’ event this year to help support patient needs …

News
larry_alleva

Adaptimmune appoints PwC head to board

March 12, 2015
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Lawrence Alleva, adaptimune, pwC

Clinical-stage biotech firm Adaptimmune has appointed Lawrence Alleva as a non-executive director who is also to serve as chairman of its …

Appointment
The Gateway to Local Adoption Series

Latest content

Kayentis and RWS partner to improve clinical trial data confidence

April 17, 2026

MHRA expands its pioneering AI Airlock programme with £3.6m funding boost

April 16, 2026

Ardena opens new US bioanalytical laboratory

April 15, 2026

Gesynta Pharma doses first patient in endometriosis phase 2 trial

April 14, 2026

Astellas Pharma’s new non-hormonal menopausal hot flush treatment Veoza can be used in the NHS, NICE says

April 13, 2026